Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 6/20 | 0.66 |
| ▸ | AKR1B10 | O60218 | 4/20 | 0.63 |
| ▸ | AKR1B1 | P15121 | 4/20 | 0.63 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | EGFR | P00533 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | MAOB | P27338 | 1/20 | 0.54 |
| ▸ | ATM | Q13315 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL356459 | 1.00 | APP (0.66) | APPAKR1B10AKR1B1HCAR2LMNA | |
| SCHEMBL356458 | 1.00 | APP (0.66) | APPAKR1B10AKR1B1HCAR2LMNA | |
| Heptyl Cinnamate SCHEMBL2290285 | 0.98 | APP (0.67) | APPAKR1B10AKR1B1HCAR2LMNA | |
| Octyl Cinnamate SCHEMBL157362 | 0.98 | APP (0.67) | APPAKR1B10AKR1B1HCAR2LMNA | |
| Heptyl Cinnamate SCHEMBL2290288 | 0.98 | APP (0.67) | APPAKR1B10AKR1B1HCAR2LMNA | |
| SCHEMBL1170007 | 0.98 | APP (0.67) | APPAKR1B10AKR1B1HCAR2LMNA | |
| SCHEMBL19460592 | 0.98 | APP (0.67) | APPAKR1B10AKR1B1HCAR2LMNA | |
| SCHEMBL13478962 | 0.98 | APP (0.67) | APPAKR1B10AKR1B1HCAR2LMNA | |
| Octyl Cinnamate SCHEMBL157363 | 0.98 | APP (0.67) | APPAKR1B10AKR1B1HCAR2LMNA | |
| SCHEMBL1170009 | 0.98 | APP (0.67) | APPAKR1B10AKR1B1HCAR2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160089317-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| US-20160090555-A1 | CLEANING AND/OR TREATMENT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160089317-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | LPO, QDPR, TYR | APP 3432/4885AKR1B10 717/4885AKR1B1 1053/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.